Dr. John Thomas Dellacroce, MD

Dr. Dellacroce practices at Freeman Health System - Siloam Springs Medical Center in Siloam Springs, Arkansas, part of Freeman Health System.

Dr. Dellacroce's NPI, 1780619718, was assigned on July 11, 2006. Dr. Dellacroce graduated from LSU Health Shreveport School of Medicine in 2002. Dr. Dellacroce holds Arkansas license E-7012.

Dr. Dellacroce's primary practice is Freeman Health System - Siloam Springs Medical Center, at 603 North Progress Avenue, Siloam Springs, AR 72761 in Benton County. The practice phone is (479) 524-4141.

Dr. Dellacroce's primary practice is Freeman Health System - Siloam Springs Medical Center in Siloam Springs, Arkansas, part of Freeman Health System. Dr. Dellacroce is also affiliated with Freeman Health System - Springdale Medical Center. The medical group on file is Retina Center of Arkansas. Dmand AI also links Dr. Dellacroce to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Dellacroce practices, 3 sites in all. Vendor and product names are available with a free account.

Retina specialist is Dr. Dellacroce's primary specialty in the NPI Registry, under taxonomy code 207WX0107X. Dr. Dellacroce is board certified in ophthalmology by the American Board of Ophthalmology. Dmand AI has Dr. Dellacroce's licenses on file in 3 states: Arkansas, Louisiana and Utah.

Dmand AI lists age-related macular degeneration, cataract, dry eye, eyelid inflammation, glaucoma, hereditary corneal conditions, hypertensive retinopathy and inflammation of iris among the conditions Dr. Dellacroce treats.

CMS data shows 59,255 Medicare services from Dr. Dellacroce across 19 procedure codes in 2024, for 1,247 Medicare patients. Medicare paid $2,603,818 for them.

CMS counts 1,247 Medicare patients who saw Dr. Dellacroce in 2024. The largest group is 65 to 74, with 534 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 4% are also on Medicaid. Their average risk score is 1.42, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Dellacroce's median patient age at 73, with 57% women.

In 2024, Dr. Dellacroce wrote 713 Medicare Part D claims for 264 patients. 65% of them were for generic drugs. CMS names the drug for 677 of them, across 9 drugs with 11 or more claims each, at $13,495 in total drug cost. In 2023, CMS named 800 claims across 9 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 98 out of 100 for Dr. Dellacroce for performance year 2024, reported as part of a group. Dr. Dellacroce accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 34 procedures of cataract surgery by Dr. Dellacroce, more than 56% of the clinicians it reports for that procedure.

Dmand AI links 6 papers to Dr. Dellacroce. The most frequent topics are Drug Evaluation, Preclinical, Electroretinography and Glucocorticoids. Dr. Dellacroce has published most often in Retina. Dr. Dellacroce's most frequent co-author is Ramesh Somayajula Ayyala, MD.

Dmand AI links Dr. Dellacroce to 11 clinical trials, 5 of them phase 2 studies. Conditions studied include Macular Degeneration, Geographic Atrophy and Retinitis Pigmentosa. Neurotech Pharmaceuticals sponsors the most, 3.

CMS Open Payments shows 146 general payments to Dr. Dellacroce from 17 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 73% of the total. Allergan Inc. paid the most, $11,558.

Dmand AI lists 11 awards for Dr. Dellacroce, most recently CMS Stage 1 EHR in 2013.

Dr. Dellacroce graduated from LSU Health Shreveport School of Medicine in 2002. Dr. Dellacroce is a member of AAO, ASRS, Arkansas Medical Society and European Retina Society.

Dr. Dellacroce is in network with 23 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Cigna. HMO plans come from the most carriers, 14. Check the plan with the practice before a visit.